BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26139426)

  • 1. Anti-mullerian hormone (AMH) is associated with natural menopause in a population-based sample: The CARDIA Women's Study.
    Nair S; Slaughter JC; Terry JG; Appiah D; Ebong I; Wang E; Siscovick DS; Sternfeld B; Schreiner PJ; Lewis CE; Kabagambe EK; Wellons MF
    Maturitas; 2015 Aug; 81(4):493-8. PubMed ID: 26139426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does anti-Müllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study.
    Depmann M; Eijkemans MJ; Broer SL; Scheffer GJ; van Rooij IA; Laven JS; Broekmans FJ
    Hum Reprod; 2016 Jul; 31(7):1579-87. PubMed ID: 27179263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Müllerian hormone, follicle stimulating hormone, antral follicle count, and risk of menopause within 5 years.
    Kim C; Slaughter JC; Wang ET; Appiah D; Schreiner P; Leader B; Calderon-Margalit R; Sternfeld B; Siscovick D; Wellons M
    Maturitas; 2017 Aug; 102():18-25. PubMed ID: 28610678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Added value of anti-Müllerian hormone in prediction of menopause: results from a large prospective cohort study.
    Dólleman M; Verschuren WM; Eijkemans MJ; Broekmans FJ; van der Schouw YT
    Hum Reprod; 2015 Aug; 30(8):1974-81. PubMed ID: 26082477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized predictions of time to menopause using multiple measurements of antimüllerian hormone.
    Gohari MR; Ramezani Tehrani F; Chenouri S; Solaymani-Dodaran M; Azizi F
    Menopause; 2016 Aug; 23(8):839-45. PubMed ID: 27326817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women.
    Freeman EW; Sammel MD; Lin H; Gracia CR
    J Clin Endocrinol Metab; 2012 May; 97(5):1673-80. PubMed ID: 22378815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal menopause as a predictor of anti-Mullerian hormone level and antral follicle count in daughters during reproductive age.
    Bentzen JG; Forman JL; Larsen EC; Pinborg A; Johannsen TH; Schmidt L; Friis-Hansen L; Nyboe Andersen A
    Hum Reprod; 2013 Jan; 28(1):247-55. PubMed ID: 23136135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of antimüllerian hormone as a biomarker of the menopausal transition.
    Iino K; Tarakida A; Abe K; Taniguchi R; Higuchi T; Takahashi I; Mizunuma H
    Menopause; 2013 Feb; 20(2):218-22. PubMed ID: 22968251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Müllerian hormone levels and incidence of early natural menopause in a prospective study.
    Bertone-Johnson ER; Manson JE; Purdue-Smithe AC; Steiner AZ; Eliassen AH; Hankinson SE; Rosner BA; Whitcomb BW
    Hum Reprod; 2018 Jun; 33(6):1175-1182. PubMed ID: 29659835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Mullerian hormone is a more accurate predictor of individual time to menopause than mother's age at menopause.
    Dólleman M; Depmann M; Eijkemans MJ; Heimensem J; Broer SL; van der Stroom EM; Laven JS; Van Rooij IA; Scheffer GJ; Peeters PH; van der Schouw YT; Lambalk CB; Broekmans FJ
    Hum Reprod; 2014 Mar; 29(3):584-91. PubMed ID: 24435779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of measuring anti-Müllerian hormone in predicting menopause.
    Aydogan B; Mirkin S
    Climacteric; 2015; 18(6):777-89. PubMed ID: 25845388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced serum levels of anti-Mullerian hormone is a putative biomarker of early knee osteoarthritis in middle-aged females at menopausal transition.
    Sasaki E; Chiba D; Ota S; Kimura Y; Sasaki S; Yamamoto Y; Oishi M; Iino K; Ando M; Tsuda E; Ishibashi Y
    Sci Rep; 2021 Mar; 11(1):4931. PubMed ID: 33654174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition.
    Sowers MR; Eyvazzadeh AD; McConnell D; Yosef M; Jannausch ML; Zhang D; Harlow S; Randolph JF
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3478-83. PubMed ID: 18593767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between ovarian reserve and preeclampsia: a cohort study.
    Erfani H; Rahmati M; Mansournia MA; Azizi F; Montazeri SA; Shamshirsaz AA; Ramezani Tehrani F
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):432. PubMed ID: 31752768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of low ovarian reserve with cardiovascular disease risk: a cross-sectional population-based study.
    de Kat AC; Verschuren WM; Eijkemans MJ; van der Schouw YT; Broekmans FJ
    Hum Reprod; 2016 Aug; 31(8):1866-74. PubMed ID: 27496945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between anti-Müllerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies.
    Dólleman M; Faddy MJ; van Disseldorp J; van der Schouw YT; Messow CM; Leader B; Peeters PH; McConnachie A; Nelson SM; Broekmans FJ
    J Clin Endocrinol Metab; 2013 May; 98(5):1946-53. PubMed ID: 23509105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Prediction of Age at Menopause Using Multiple Anti-Müllerian Hormone Measurements: the Tehran Lipid-Glucose Study.
    Ramezani Tehrani F; Bidhendi Yarandi R; Solaymani-Dodaran M; Tohidi M; Firouzi F; Azizi F
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32109280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The physiology and clinical utility of anti-Mullerian hormone in women.
    Dewailly D; Andersen CY; Balen A; Broekmans F; Dilaver N; Fanchin R; Griesinger G; Kelsey TW; La Marca A; Lambalk C; Mason H; Nelson SM; Visser JA; Wallace WH; Anderson RA
    Hum Reprod Update; 2014; 20(3):370-85. PubMed ID: 24430863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimullerian Hormone and Impending Menopause in Late Reproductive Age: The Study of Women's Health Across the Nation.
    Finkelstein JS; Lee H; Karlamangla A; Neer RM; Sluss PM; Burnett-Bowie SM; Darakananda K; Donahoe PK; Harlow SD; Prizand SH; Joffe H; Kumar A; Martin DE; McConnell D; Merrilat S; Morrison A; Pastore LM; Randolph JF; Greendale GA; Santoro N
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1862-71. PubMed ID: 31965189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition.
    van Rooij IA; Tonkelaar Id; Broekmans FJ; Looman CW; Scheffer GJ; de Jong FH; Themmen AP; te Velde ER
    Menopause; 2004; 11(6 Pt 1):601-6. PubMed ID: 15545787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.